Document is current
Any future updates will be listed below
-
Authors
Szafran, Agnieszka
Kurt, Berkan
Pracht, Jessica
Zechendorf, Elisabeth
Breuer, Thomas
Stoppe, Christian
Marx, Gernot
Tacke, Frank
Kahles, Florian
Mossanen, Jana C
-
Funding
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
- License Information
-
More Information
Article History
Received: 1 March 2026
Accepted: 8 April 2026
First Online: 25 April 2026
Declarations
:
: B.K. has served as a speaker for SphingoTec/4TEEN4 Pharmaceuticals and Novo Nordisk and received travel reimbursement from 4TEEN4 Pharmaceuticals, Novo Nordisk, the German Society of Lipidology, the German Cardiac Society, Boehringer Ingelheim, and Lilly. F.K. has served as a speaker for Novo Nordisk, Amgen, Lilly, AstraZeneca, C.T.I., Cogitando, and DGK-Akademie; consulted for Novo Nordisk, Lilly, Bayer, and PricewaterhouseCoopers/Strategy&; and received travel support from Amgen, Novo Nordisk, Boehringer Ingelheim, Bayer, SphingoTec/4TEEN4 Pharmaceuticals, C.T.I., Cogitando, and Lilly. All other authors declare that they have no competing interests.
